Breast cancer survival in the TCGA dataset was not significantly affected by CTDP1 expression (p = 0.52) (Fig. S3D), but a separate database assembled by PRECOG37 of 16 different breast cancer studies determined that elevated CTDP1 expression correlates with decreased survival (z-score = 2.2, p = 0.028) (Fig. S3E). Here, CTDP1 is linked to breast cancer.